Large B Cell Lymphoma with MYC Rearrangement Is Associated with High P53 Expression and a Poor Prognosis Similar to MYC/BCL2 Double Hit Lymphoma

被引：0
|
作者：
Weiss, V. L.
Wang, X. J.
Medeiros, L. J.
Li, S.
机构：
[1] Vanderbilt Univ, Nashville, TN 37235 USA
[2] UT MD Anderson Canc Ctr, Houston, TX USA
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1580
引用
收藏
页码：385A / 385A
页数：1
相关论文
共 50 条
  • [21] GENOMIC PROFILING OF BCL2 AND MYC DOUBLE EXPRESSOR DIFFUSE LARGE B CELL LYMPHOMA
    Dirse, V.
    Drachneris, J.
    Mickys, U.
    Stoskus, M.
    Griskevicius, L.
    HAEMATOLOGICA, 2017, 102 : 574 - 574
  • [22] Clinical Features and Prognosis Analysis of 168 Cases of MYC/BCL2 Double Expression Diffuse Large B Lymphoma
    Chen, Qingfeng
    Liu, Tingbo
    Shen, Jianzhen
    Li, Xiaofan
    BLOOD, 2023, 142
  • [23] Prognostic Significance of Double Expression of C-MYC and BCL2 in Diffuse Large B Cell Lymphoma
    Rashed, Hayam
    Abdelrahman, Aziza Elsayed
    Ismail, Eman
    Obaya, Ahmed
    Abdelhamid, Mohamed
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S360 - S360
  • [24] Targeting MYC and BCL2 by a natural compound for "double-hit" lymphoma
    Liu, Xiaoqian
    Xu, Senlin
    Zhang, Jiawei
    Fan, Mingjie
    Xie, Jun
    Zhang, Bingfeng
    Li, Hongzhi
    Yu, Guohua
    Liu, Yinghui
    Zhang, Yuanfeng
    Song, Joo
    Horne, David
    Chan, Wing C.
    Chu, Xiaoxia
    Huang, Wendong
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (03) : 356 - 369
  • [25] MYC/BCL2 Double-Hit (DHL) and MYC aberrations Correlate with a Worse Outcome within MYC/BCL2 Protein Double-Positive (DPL) High-Grade B Cell Lymphoma
    Wang, X. J.
    Medeiros, L. J.
    Thompson, M. A.
    Lin, P.
    Yin, C. C.
    Abel, T. W.
    Li, S.
    MODERN PATHOLOGY, 2014, 27 : 384A - 385A
  • [26] Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable
    Landsburg, Daniel J.
    Falkiewicz, Marissa K.
    Petrich, Adam M.
    Chu, Benjamin A.
    Behdad, Amir
    Li, Shaoying
    Medeiros, L. Jeffrey
    Cassaday, Ryan D.
    Reddy, Nishitha M.
    Bast, Martin A.
    Vose, Julie M.
    Kruczek, Kimberly R.
    Smith, Scott E.
    Patel, Priyank
    Hernandez-Ilizaliturri, Francisco
    Karmali, Reem
    Rajguru, Saurabh
    Yang, David T.
    Maly, Joseph J.
    Blum, Kristie A.
    Zhao, Weiqiang
    Vanslambrouck, Charles
    Nabhan, Chadi
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 175 (04) : 631 - 640
  • [27] Low incidence of MYC/BCL2 double-hit in Burkitt lymphoma
    Yoshida, Maki
    Ichikawa, Ayako
    Miyoshi, Hiroaki
    Kiyasu, Junichi
    Kimura, Yoshizo
    Niino, Daisuke
    Ohshima, Koichi
    PATHOLOGY INTERNATIONAL, 2015, 65 (09) : 486 - 489
  • [28] MYC/BCL2 Double-Hit (DHL) and MYC aberrations Correlate with a Worse Outcome within MYC/BCL2 Protein Double-Positive (DPL) High-Grade B Cell Lymphoma
    Wang, X. J.
    Medeiros, L. J.
    Thompson, M. A.
    Lin, P.
    Yin, C. C.
    Abel, T. W.
    Li, S.
    LABORATORY INVESTIGATION, 2014, 94 : 384A - 385A
  • [29] BCL2 and MYC Protein Expression in Primary Testicular Diffuse Large B Cell Lymphoma
    Gascoyne, R. D.
    Tan, K. L.
    Ben-Neriah, S.
    Savage, K. J.
    Telio, D.
    Hung, T.
    Connors, J. M.
    Scott, D. W.
    Steidl, C.
    Slack, G. W.
    MODERN PATHOLOGY, 2012, 25 : 336A - 336A
  • [30] MYC-Rearrangement and MYC/BCL2 Double Expression but not Cell-of-Origin Predict Prognosis in de novo Diffuse Large B-Cell Lymphoma Treated with R-CHOP
    Liu, Jing-Lan
    Medeiros, L. Jeffrey
    Huang, Wenting
    McDonnell, Timothy
    Miranda, Roberto
    Bueso-Ramos, Carlos
    Schlette, Ellen
    Lin, Pei
    Li, Shaoying
    MODERN PATHOLOGY, 2018, 31 : 534 - 534
12345